Mingyue Xu

机构：Chinese Academy of Sciences, Chinese Academy of Medical Sciences & Peking Union Medical College, Jinan Maternity And Care Hospital, Institute of Genetics and Developmental Biology, Institute of Hematology & Blood Diseases Hospital, Shandong Maternal and Child Health Hospital, Shandong First Medical University · ORCID：0009-0003-7793-344X

发表论文 76 篇 · 总被引 8990 次 · h-index 20

代表论文

• cGAS-STING activation contributes to podocyte injury in diabetic kidney disease (2022 · iScience · 被引 106)
• Ru-decorated cobalt-iron oxide nanosheet arrays derived from MOF and LDH double-precursors for overall water splitting in alkali and seawater (2023 · Electrochimica Acta · 被引 38)
• Obinutuzumab versus rituximab for the treatment of refractory primary membranous nephropathy (2024 · Nephrology Dialysis Transplantation · 被引 35)
• Matrix protein Tenascin-C promotes kidney fibrosis via STAT3 activation in response to tubular injury (2022 · Cell Death and Disease · 被引 24)
• Targeted ablation of signal transducer and activator of transduction 1 alleviates inflammation by microglia/macrophages and promotes long-term recovery after ischemic stroke (2023 · Journal of Neuroinflammation · 被引 21)
• Serum Isthmin-1 is negatively correlated with HDL-C in type 2 diabetes mellitus (2023 · Journal of Diabetes and its Complications · 被引 14)